Hypoglycemic and hypolipidemic effects of aqueous extract of phaseolus vulgaris pods in streptozotocin-diabetic rats

Biomedicine and Pharmacotherapy

Volumn 94, Issue , 2017, Pages 742-746

  Almuaigel, Mohammad Faisal ^a   Seif, Mosaad A ^a   Albuali, Hamad Waleed ^a   Alharbi, Omar ^a   Alhawash, Amer ^a  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Diabetes; Hypoglycemic; Hypolipidemic; Phaseolus vulgaris pods; Saudi Arabia

Indexed keywords

CHOLESTEROL; GLIBENCLAMIDE; PHASEOLUS VULGARIS EXTRACT; PLANT EXTRACT; STREPTOZOCIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; LIPID;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; NONHUMAN; PHASEOLUS VULGARIS; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; HYPERGLYCEMIA; ISOLATION AND PURIFICATION; ORAL DRUG ADMINISTRATION; PHASEOLUS; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; LIPIDS; PHASEOLUS; PLANT EXTRACTS; RATS; RATS, WISTAR; STREPTOZOCIN; TRIGLYCERIDES;

EID: 85026863191     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.07.135     Document Type: Article

References (31)

1. Newman, J.D., Rockman, C.B., Kosiborod, M., Guo, Y., Zhong, H., Weintraub, H.S., Schwartzbard, A.Z., Adelman, M.A., Berger, J.S., Diabetes mellitus is a coronary heart disease risk equivalent for peripheral vascular disease. Am. Heart J. 184:February (2017), 114–120.
2. Meikle, P.J., Summers, S.A., Sphingolipids and phospholipids in insulin resistance and related metabolic disorders. Nature Rev. Endocrinol. 13:February (2) (2017), 79–91.
3. Kennedy, M.W., Fabris, E., Hermanides, R.S., Kaplan, E., Borren, N., Berta, B., Koopmans, P.C., Ottervanger, J.P., Suryapranata, H., Kedhi, E., Factors associated with deferred lesion failure following fractional flow reserve assessment in patients with diabetes mellitus. Catheter. Cardiovasc. Interv.(March), 2017.
4. Patel, D.K., Kumar, R., Prasad, S.K., Sairam, K., Hemalatha, S., Antidiabetic and in vitro antioxidant potential of Hybanthus enneaspermus (Linn) F. Muell in streptozotocin-induced diabetic rats. Asian Pac. J. Trop. Biomed. 1:4 (2011), 316–322.
5. Cariou, B., Leiter, L.A., Müller-Wieland, D., Bigot, G., Colhoun, H.M., Del Prato, S., Henry, R.R., Tinahones, F.J., Letierce, A., Aurand, L., Maroni, J., Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: rationale and design of the ODYSSEY DM–INSULIN trial. Diabetes Metabolism(March), 2017.
6. Wilson Tang, W.H., Maroo, A., Young, J.B., Ischemic heart disease and congestive heart failure in diabetic patients. Med. Clin. North Am. 88 (2004), 1037–1061.
7. Scott, R., VanVliet, G., Deladoëy, J., Association of adrenal insufficiency with insulin-dependent diabetes mellitus in a patient with inactivating mutations in nicotinamide nucleotide transhydrogenase: a phenocopy of the animal model. Eur. J. Endocrinol. 176:Mrach (3) (2017), C1–C2.
8. Gamit, S.T., Gamit, A.L., Patel, T.C., Bhatt, P., Chaudhari, V.P., WHR (waist hip ratio) as risk factor irrespective of body mass index (BMI) among patients of noninsulin dependent diabetes mellitus (NIDDM). Int. J. Res. Med. 5:4 (2017), 68–72.
9. Qaseem, A., Barry, M.J., Humphrey, L.L., Forciea, M.A., Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline update from the american college of physicians oral pharmacologic treatment of type 2 diabetes mellitus. Ann. Intern. Med.(January), 2017.
10. Fajans SS, Floyd Jr JC, Knopf RF, Conn JW. Effect of amino acids and proteins on insulin secretion in man. InSchering Symposium on Endocrinology, Berlin,M ay 26 to 27, 1967: Advances in the Biosciences 2016 Jul 29 (Vol. 1, p. 231). Elsevier.
11. Calvo-Maroto, A.M., Pérez-Cambrodí, R.J., García-Lázaro, S., Albarrán-Diego, C., Cerviño, A., A pilot study on total, corneal, and internal aberrations in insulin-dependent and non-insulin-dependent diabetes mellitus patients. Graefe's Archive Clin. Experiment. Ophthalmol. 253:April (4) (2015), 645–653.
12. Liu, C., Wu, D., Zheng, X., Li, P., Li, L., Efficacy and safety of metformin for patients with type 1 diabetes mellitus: a meta-analysis. Diabetes Technol. Therapeut. 17:February (2) (2015), 142–148.
13. Kumar, A., Ilavarasan, R., Jayachandran, T., Decaraman, M., Aravindan, P., Padmanabhan, N., Krishnan, M.V., Anti-diabetic activity of Syzygium cumini and its isolated compound against streptozotocin-induced diabetic rats. J. Med. Plant Res. 2 (2008), 246–249.
14. Bedekar, A., Shah, K., Koffas, M., Allen, I.L., Sima, S., Geoffrey, M.G., Chapter 2 − natural products for type II diabetes treatment. Adv. Appl. Microbiol. 71 (2010), 21–73.
15. Gandhi, G.R., Ignacimuthu, S., Paulraj, M.G., Sasikumar, P., Antihyperglycemic activity and antidiabetic effect of methyl caffeate isolated from Solanum torvum Swartz. Fruit in streptozotocin induced diabetic rats. Eur. J. Pharm. 670 (2011), 623–631.
16. Gupta, S., Sidhu, M.C., Ahluwalia, A.S., Plant-based remedies for the management of diabetes. Curr. Botany 8:March (2017), 34–40.
17. Kyznetsova, M.Y., Makieieva, O.M., Lavrovska, D.O., Tymoshenko, M.O., Sheverova, D.P., Halenova, T.I., Savchuk, O.M., Ostapchenko, L.I., Effect of aqueous extract from phaseolus vulgaris pods on lipid peroxidation and antioxidant enzymes activity in the liver and kidney of diabetic rats. J. Appl. Pharm. Sci. 5:May (5) (2015), 001–006.
18. Ramírez-Jiménez, A.K., Reynoso-Camacho, R., Tejero, M.E., León-Galván, F., Loarca-Piña, G., Potential role of bioactive compounds of Phaseolus vulgaris L. on lipid-lowering mechanisms. Food Res. Int. 76:October (2015 Oct), 92–104.
19. Alam S, Siddiq A, Hasan MM. HYPOLIPIDEMIC EFFECT OF PHASEOLUS VULGARIS L. AT VARIOUS DOSES AND ITS IMPACT ON CARDIOVASCLUAR.
20. Park, K.H., Yoon, K.H., Yin, J., Le TT, Ahn HS, Yoon, S.H., Lee, M.W., Antioxidative and anti-Inflammatory activities of galloyl derivatives and antidiabetic activities of acer ginnala. Evidence-Based Complementary Alternat. Med., 2017(March), 2017.
21. Muruganathan, U., Srinivasan, S., Vinothkumar, V., Antidiabetogenic efficiency of menthol, improves glucose homeostasis and attenuates pancreatic β-cell apoptosis in streptozotocin–nicotinamide induced experimental rats through ameliorating glucose metabolic enzymes. Biomed. Pharmacother. 92 (2017), 229–239.
22. Raimann, J.G., Riella, M.C., Levin, N.W., International Society of Nephrology's 0by25 initiative (zero preventable deaths from acute kidney injury by 2025): focus on diagnosis of acute kidney injury in low-income countries. Clin. Kidney J.(February), 2017.
23. Nawale, R.B., Mate, G.S., Wakure, B.S., Ethanolic extract of Amaranthus paniculatus Linn. ameliorates diabetes-associated complications in alloxan-induced diabetic rats. Integrative Med. Res. 6:March(1) (2017), 41–46.
24. Gomez, Y., Diaz-Solano, D., Gledhill, T., Wittig, O., Cardier, J., The effect of G-CSF and AMD3100 on mice treated with streptozotocin: expansion of alpha-cells and partial islet protection. Cytokine 96:August (2017), 123–131.
25. Helmstädter, A., Beans and diabetes: phaseolus vulgaris preparations as antihyperglycemic agents. J. Med. Food 13:2 (2010), 251–254.
26. Mudi, S.R., Akhter, M., Biswas, S.K., Muttalib, M.A., Choudhury, S., Rokeya, B., Ali, L., Effect of aqueous extract of Aegle marmelos fruit and leaf on glycemic, insulinemic and lipidemic status of type 2 diabetic model rats. J. Complement. Integrat. Med., 14(March (2)), 2017.
27. Ocho-Anin Atchibri, A.L., Brou, K.D., Kouakou, T.H., Kouadio, Y.J., Gnakri, D., Screening for antidiabetic activity and phytochemical constituents of common bean (Phaseolus vulgaris L.) seeds. J. Med. Plants Res. 4:17 (2010), 1757–1761.
28. Namekawa, J., Takagi, Y., Wakabayashi, K., Nakamura, Y., Watanabe, A., Nagakubo, D., Shirai, M., Asai, F., Effects of high-fat diet and fructose-rich diet on obesity, dyslipidemia and hyperglycemia in the WBN/Kob-Leprfa rat, a new model of type 2 diabetes mellitus. J. Vet. Med. Sci. 21:April (2017), 17–0136.
29. Armenian, S.H., Chemaitilly, W., Chen, M., Chow, E.J., Duncan, C.N., Jones, L.W., Pulsipher, M.A., Remaley, A.T., Rovo, A., Salooja, N., Battiwalla, M., National institutes of health hematopoietic cell transplantation late effects initiative: the cardiovascular disease and associated risk factors working group report. Biol. Blood Marrow Transplant. 23:February (2) (2017), 201–210.
30. Wang, D., Zhao, X., Liu, Y., Hypoglycemic and hypolipidemic effects of a polysaccharide from flower buds of Lonicera japonica in streptozotocin-induced diabetic rats. Int. J. Biol. Macromol. 102:September (2017), 396–404.
31. Dong, P., Pan, L., Zhang, X., Zhang, W., Wang, X., Jiang, M., Chen, Y., Duan, Y., Wu, H., Xu, Y., Zhang, P., Hawthorn (Crataegus pinnatifida Bunge) leave flavonoids attenuate atherosclerosis development in apoE knock-out mice. J. Ethnopharmacol. 198:February (2017), 479–488.